Downregulation by tumor necrosis factor-α of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: A potential mechanism of monocyte retention in atherosclerotic lesions

Atherosclerosis

Volumn 145, Issue 1, 1999, Pages 115-123

  Weber, Christian ^a   Draude, Georg ^a   Weber, Kim S C ^a   Wübert, Joachim ^a   Lorenz, Reinhard L ^a   Weber, Peter C ^a  

^a Inst Prophylaxe K   (Germany)

Author keywords

Atherosclerosis; Chemokines; Cytokines; Endothelium; Lipoproteins; Monocyte

Indexed keywords

CELL RECEPTOR; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL DIFFERENTIATION; CELL INFILTRATION; CHEMOTAXIS; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; LIPID PEROXIDATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; LIPOPROTEINS, LDL; MONOCYTES; OXIDATION-REDUCTION; POLYMERASE CHAIN REACTION; RECEPTORS, CHEMOKINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033049705     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00021-0     Document Type: Article

References (39)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
2. Galis Z.S., Sukhova G.K., Kranzhöfer R., Clark S., Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA. 92:1995;402-406.
3. Moreno P.R., Bernardi V.H., Lopez-Cuellar J., Murcia A.M., Palacios I.F., Gold H.K., Mehran R., Sharma S.K., Nemerson Y., Fuster V., Fallon T.J. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 94:1996;3090-3097.
4. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
5. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related CC chemotactic cytokines - CXC and CC chemokines. Adv Immunol. 55:1994;97-179.
6. Weber C., Alon R., Moser B., Springer T.A. Sequential regulation of α4β1 and α5β1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J Cell Biol. 134:1996;1063-1073.
7. Charo I.F., Myers S.J., Herman A., Franci C., Connolly A.J., Coughlin S.R. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxy-terminal tails. Proc Natl Acad Sci USA. 91:1994;2752-2756.
8. Boring L., Gosling J., Chensue S.W., Kunkel S.L., Farese R.V.J. Jr., Broxmeyer H.E., Charo I.F. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest. 100:1997;2552-2561.
9. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med. 186:1997;1757-1762.
10. Kuziel W.A., Morgan S.J., Dawson T.C., Griffin S., Smithies O., Ley K., Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA. 94:1997;12053-12058.
11. Power C.A., Meyer A., Nemeth K., Bacon K.B., Hoogewerf A.J., Proudfoot A.E.I., Wells T.N.C. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem. 270:1995;19495-19500.
12. Imai T., Baba M., Nishimura M., kakizaki M., Tagaki S., Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 272:1997;15036-15042.
13. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
14. Ylä-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., Witztum J.L., Steinberg D. Expression of monocyte chemotactic protein-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA. 88:1991;5252-5256.
15. Steinberg D., Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation. 95:1997;1062-1071.
16. Libby P., Hansson G.K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 64:1991;5-15.
17. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
18. Randolph G.J., Furie M.B. Mononuclear phagocytes egress from an in vitro model of the vascular wall by migrating across endothelium in the basal to apical direction: role of intercellular adhesion molecule 1 and the CD11/CD18 integrins. J Exp Med. 183:1996;451-462.
19. Weber C., Erl W., Weber P.C. Enhancement of monocyte adhesion to endothelial cells by modified low density lipoprotein is mediated via activation of CD11b. Biochem Biophys Res Commun. 206:1995;621-628.
20. Weber C., Aepfelbacher M., Haag H., Ziegler-Heitbrock H.W.L., Weber P.C. Tumor necrosis factor induces enhanced responses to platelet activating factor and differentiation in human monocytic Mono Mac 6 cells. Eur J Immunol. 23:1993;852-859.
21. Erl W., Weber P.C., Weber C. Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis. 136:1998;297-303.
22. Kirtharides L., Jessup W., Gifford J., Dean R.T. A method for defining the stages of LDL oxidation by the separation of cholesterol and cholesteryl ester oxidation products. Anal Biochem. 213:1993;79-89.
23. Suarna C., Dean R.T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler Thromb. 15:1995;1616-1624.
24. Weber C., Erl W., Pietsch A., Ströbel M., Ziegler-Heitbrock H.W.L., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb. 14:1994;1665-1673.
25. Weber C., Erl W., Pietsch A., Weber P.C. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation. 91:1995;1914-1917.
26. Carr M.W., Roth S.J., Luther E., Rose S.S., Springer T.A. Monocyte chemoattractant protein-1 is a major T lymphocyte chemoattractant. Proc Natl Acad Sci USA. 91:1994;3652-3656.
27. 2-terminal residues. J Exp Med. 181:1995;631-640.
28. Qin S., LaRosa G., Campbell J.J., Smith-Heath H., Kassam N., Shi X., Zeng L., Butcher E.C., Mackay C.R. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur J Immunol. 26:1996;640-647.
29. Sica A., Saccani A., Borsatti A., Power C.A., Wells T.N.C., Luini W., Polentarutti N., Sozzani S., Mantovani A. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med. 185:1997;969-974.
30. Feil C., Augustin H.G. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun. 247:1998;38-45.
31. Erl W., Weber C., Wardemann C., Weber P.C. Adhesion properties of Mono Mac 6, a monocytic cell line with characteristics of mature human monocytes. Atherosclerosis. 113:1995;99-106.
32. Weber C., Lu C.F., Casasnovas J., Springer T.A. Role of αLβ2 integrin avidity in transendothelial chemotaxis of mononuclear cells. J Immunol. 159:1997;3968-3975.
33. Roth P., Stanley E.R. The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol. 181:1992;141-167.
34. Campbell J.J., Qin S., Bacon K.B., Mackay C.R., Butcher E.C. Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells. J Cell Biol. 134:1996;255-266.
35. Tangirala R.K., Murao K., Quehenberger O. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J Biol Chem. 272:1997;8050-8056.
36. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., Lusis A.J. Atherosclerosis: basic mechanisms, oxidation, inflammation and genetics. Circulation. 91:1995;2488-2496.
37. Stengel D., Antonucci M., Arborati M., Hourton D., Griglio S., Chapman M.J., Ninio I. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL. Arterioscler Thromb Vasc Biol. 17:1997;954-962.
38. Hamilton T.A., Major J.A., Chisolm G.M. The effects of oxidized low-density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent. J Clin Invest. 95:1995;2020-2027.
39. Ohlsson B.G., Englund M.C., Karlsson A.L., Knutsen E., Erixon C., Skribeck H., Liu Y., Bondjers G., Wiklund O. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-κB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages. J Clin Invest. 98:1996;78-89.